Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 275 of 2529 entries
View as:

Comparison of Clinical Outcomes Among Patients Treated With Tisagenlecleucel

Phase: N/A Priority: Normal
NCT ID: NCT05541328 Org: User:
Start: 02/03/20 End: 02/05/21 Due: 02/05/22

A Long-term Safety Study in Brazilian Patients With a Diagnosis of Spinal Muscular Atrophy Treated With Zolgensma

Phase: N/A Priority: Normal
NCT ID: NCT06019637 Org: User:
Start: 11/22/23 End: 09/30/38 Due: 09/30/39

Study to Identify and Describe Predictive Factors for Thromboembolic Events in Patients With High-risk Polycythemia Vera

Phase: N/A Priority: Normal
NCT ID: NCT05548062 Org: User:
Start: 03/02/23 End: 08/31/27 Due: 08/31/28

Study of Treatment With Nilotinib in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase

Phase: N/A Priority: Normal
NCT ID: NCT00786812 Org: User:
Start: 08/31/08 End: 01/31/12 Due: 01/31/13

Study of Efficacy of Fevipiprant in Patients With Nasal Polyposis and Asthma

Phase: N/A Priority: Normal
NCT ID: NCT03681093 Org: User:
Start: 03/26/19 End: 06/10/20 Due: 06/10/21

Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant

Phase: N/A Priority: Normal
NCT ID: NCT00099749 Org: User:
Start: 11/30/03 End: - Due: -

Efficacy and Safety of FTY720 in Patients Who Receive a Kidney Transplant

Phase: N/A Priority: Normal
NCT ID: NCT00099736 Org: User:
Start: 05/07/03 End: 09/19/05 Due: 09/19/06

Study of Capmatinib and Spartalizumab/Placebo in Advanced NSCLC Patients With MET Exon 14 Skipping Mutations

Phase: N/A Priority: Normal
NCT ID: NCT04323436 Org: User:
Start: 08/19/20 End: 01/26/23 Due: 01/26/24

Pharmacokinetics and Pharmacodynamics of BCT194 in Psoriatic Patients

Phase: N/A Priority: Normal
NCT ID: NCT01539915 Org: User:
Start: 04/30/07 End: - Due: -

To Assess the Efficacy of the Investigational Products Compared to Placebo in Participants With IPF

Phase: N/A Priority: Normal
NCT ID: NCT05497284 Org: User:
Start: 11/10/22 End: 09/26/24 Due: 09/26/25

A Study to Assess COVID-19 Vaccination Immune Response in Multiple Sclerosis Patients Treated With Ofatumumab

Phase: N/A Priority: Normal
NCT ID: NCT06460324 Org: User:
Start: 05/20/22 End: 07/03/23 Due: 07/03/24

Observational Study for Melanoma Adjuvant Treatment With Tafinlar® + Mekinist® (Dabrafenib + Trametinib)

Phase: N/A Priority: Normal
NCT ID: NCT04547946 Org: User:
Start: 10/15/21 End: 06/07/22 Due: 06/07/23

Study of Efficacy and Safety of Fingolimod (Gilenya) 0.5 mg in Chinese Patients With Relapsing Multiple Sclerosis (RMS) Patients

Phase: N/A Priority: Normal
NCT ID: NCT04667949 Org: User:
Start: 02/20/21 End: 03/25/25 Due: 03/25/26

Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01482156 Org: User:
Start: 01/31/12 End: 02/28/15 Due: 02/28/16

Efficacy and Safety of Vildagliptin 50mg Bid as an add-on Therapy to Insulin With or Without Metformin, in Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01582230 Org: User:
Start: 04/30/12 End: 05/31/13 Due: 05/31/14

A Safety and Efficacy Study of Remibrutinib in the Treatment of CSU in Japanese Adults Inadequately Controlled by H1-antihistamines

Phase: N/A Priority: Normal
NCT ID: NCT05048342 Org: User:
Start: 01/15/22 End: 12/09/23 Due: 12/09/24

A Study to Evaluate the Impact of Long-term Digital Education vs Standard of Care on LDL-C Levels in Post Myocardial Infarction Patients

Phase: N/A Priority: Normal
NCT ID: NCT06548555 Org: User:
Start: 03/08/23 End: 10/24/24 Due: 10/24/25

Study of Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With an Allergy to Peanuts

Phase: N/A Priority: Normal
NCT ID: NCT05432388 Org: User:
Start: 10/12/22 End: 03/11/25 Due: 03/11/26

Safety, Tolerability and Preliminary Efficacy of Multiple Intra-articular Injections of LRX712 in Patients With Knee OA

Phase: N/A Priority: Normal
NCT ID: NCT04097379 Org: User:
Start: 07/20/20 End: 01/17/25 Due: 01/17/26

Safety and Efficacy Study of Femara(Letrozole) as an Extended Adjuvant Treatment in Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01249456 Org: User:
Start: 05/31/06 End: 04/30/15 Due: 04/30/16

A Phase Ib, Open-label, Multi-center Dose-finding Study of Oral Panobinostat (LBH589) in Combination With Ara-C and Mitoxantrone as Salvage Therapy for Refractory or Relapsed Acute Myeloid Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT01055483 Org: User:
Start: 09/30/09 End: 02/29/12 Due: 02/28/13

Study to Evaluate Panobinostat (DACi) Pharmacokinetics and Safety in Solid Tumors and Varying Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT00997399 Org: User:
Start: 03/31/10 End: 06/30/14 Due: 06/30/15

Efficacy of Everolimus as Inhibitor of Fibrosis Progression in Liver Transplant Patients With Recurrence of Hepatitis C Viral Infection

Phase: N/A Priority: Normal
NCT ID: NCT00582738 Org: User:
Start: 12/31/07 End: 01/31/10 Due: 01/31/11

Effectiveness of Ofatumumab in Real-world Practice

Phase: N/A Priority: Normal
NCT ID: NCT06760624 Org: User:
Start: 10/24/23 End: 01/15/24 Due: 01/15/25

Efficacy and Safety of Sacubitril/Valsartan Compared With Enalapril on Morbidity, Mortality, and NT-proBNP Change in Patients With CCC

Phase: N/A Priority: Normal
NCT ID: NCT04023227 Org: User:
Start: 12/10/19 End: 03/31/25 Due: 03/31/26